Levocetirizine + Montelukast (Levocetirizine + Montelukast) is a highly effective, advanced combination medicine used to manage and relieve symptoms of various allergies. Containing Levocetirizine and Montelukast , it provides fast and consistent 24-hour relief from common allergic reactions such as hay fever (seasonal allergic rhinitis), persistent year-round allergies, and chronic respiratory conditions like asthma. By blocking the action of natural histamine and leukotrienes, Levocetirizine + Montelukast significantly reduces sneezing, runny nose, nasal congestion, wheezing, and skin itching, allowing patients to maintain their daily routine without the discomfort of allergies.

Levocetirizine + Montelukast is a trusted, dual-action medication prescribed for the comprehensive and long-term control of both respiratory and dermatological allergic conditions. The active pharmaceutical ingredient, Levocetirizine, is a potent, selective H1-receptor antagonist.

The body’s natural defence mechanism against environmental triggers like pollen, dust mites, or pet dander involves releasing a chemical called histamine. Histamine binds to H1 Receptors, triggering a cascade of uncomfortable allergy symptoms—inflammation, fluid leakage leading to a runny nose, and intense itching. Levocetirizine + Montelukast works by powerfully and selectively binding to these peripheral H1-receptors, effectively preventing histamine from attaching and exerting its adverse effects.

Montelukast, the second component, is a leukotriene receptor antagonist that blocks cysteinyl leukotriene receptors (CysLT1). Leukotrienes are inflammatory chemicals released in response to allergens that cause airway inflammation, bronchoconstriction, and mucus production. By inhibiting these receptors, Montelukast helps reduce airway swelling, improve breathing, and control symptoms of asthma and allergic rhinitis.

This inhibition not only provides symptomatic relief but also helps stabilise the allergic response. Consistent, once-daily administration helps keep the body's histamine and leukotriene levels in check throughout the day and night. Levocetirizine + Montelukast requires a prescription and should always be used under the guidance of a registered healthcare professional to ensure correct dosage and duration.

Levocetirizine + Montelukast is prescribed for the following clinical indications:

Treatment of Seasonal Allergic Rhinitis (Hay Fever):

Effectively relieves nasal congestion, sneezing, nasal itching, and watery, itchy eyes caused by seasonal allergens such as pollen.

Management of Perennial Allergic Rhinitis:

Provides year-round relief from chronic allergy symptoms triggered by non-seasonal allergens such as pet dander, mould spores, and house dust mites.

Relief from Chronic Idiopathic Urticaria (Chronic Hives):

Significantly reduces the uncomfortable symptoms of itching (pruritus), swelling, and the appearance of persistent red, raised welts associated with chronic hives of unknown cause.

Treatment of Allergic Skin Manifestations:

Used to alleviate itching and rash associated with various acute and chronic non-infectious allergic skin reactions.

Choosing Levocetirizine + Montelukast provides essential allergy management advantages:

Maximum Potency:

Delivers powerful H1-receptor blockade at a low five mg dose of Levocetirizine combined with effective leukotriene receptor antagonism by Montelukast, ensuring high efficacy.

Twenty-Four-Hour Control:

Just one tablet daily provides sustained symptom relief for a full day, improving patient compliance.

Low Sedation Risk:

As Levocetirizine is a second-generation antihistamine, it has minimal drowsiness risk, helping you stay alert during daily activities.

Rapid Action:

Works quickly, with symptom relief often beginning within 60 minutes of the first dose.

Enhances Sleep:

Controls nocturnal symptoms like itching and post-nasal drip, improving overall sleep quality and well-being.

While Levocetirizine + Montelukast is generally well-tolerated, some individuals may experience side effects. The severity and occurrence of side effects are often dose-related and temporary. If any of these effects persist or worsen, consult your doctor.

Common Side Effects (May occur in more than one in ten people):

• Drowsiness, fatigue, or tiredness (somnolence) usually improve with continued use.

• Dry mouth (xerostomia) is often manageable with increased fluid intake.

• Headache, typically mild and transient.

• Inflammation of the pharynx (sore throat), which may accompany cold-like symptoms.

Uncommon or Rare Side Effects (Require medical attention if severe):

• Gastrointestinal upset, including nausea, vomiting, or abdominal pain; seek medical advice if persistent.

• Hypersensitivity Reactions, such as swelling of the face, lips, tongue, or throat (angioedema), difficulty breathing, or severe rash, require immediate emergency care.

• Vision disturbances, including blurred vision or other changes; report promptly to your doctor.

• Difficulty or inability to pass urine (urinary retention), which may require urgent medical evaluation.

• Irregular heartbeat (tachycardia); seek medical advice if this occurs.

• Follow your doctor’s instructions precisely when taking Levocetirizine + Montelukast.

• Swallow the tablet whole with a sufficient amount of water. Do not crush, chew, or break the tablet, as this can affect its release mechanism and efficacy.

• The medicine can be taken with or without food, making it convenient to fit into your routine.

• It is typically taken once daily for optimal control of allergic symptoms.

• For patients who experience mild drowsiness, taking the dose in the evening or before bedtime is often recommended to minimise daytime sleepiness.

• Do not exceed the dosage or duration prescribed by your doctor. If symptoms do not improve or worsen after the prescribed course, seek further medical advice to reassess your treatment.

Levocetirizine + Montelukast combines two actions to relieve allergy symptoms. Levocetirizine is a selective H1-receptor antagonist that blocks histamine, preventing symptoms like sneezing, itching, and runny nose. It also reduces inflammatory cell activity. Montelukast is a leukotriene receptor antagonist that blocks leukotriene D4, reducing airway inflammation, swelling, and mucus production. Together, they effectively control allergy and asthma symptoms by targeting different inflammatory pathways.

• Take the entire course of Levocetirizine + Montelukast as prescribed by your doctor, even if symptoms improve.

• If you feel drowsy, switch your dose to the evening or before bedtime. Avoid alcohol to reduce the risks of sedation and dizziness.

• Be cautious when driving or doing tasks that need focus until you know how the medicine affects you.

• Always inform your doctor or pharmacist about other medications or supplements you are taking.

• Store Levocetirizine + Montelukast at room temperature below 25°C.

• Keep it in a cool, dry place away from direct sunlight, heat, and moisture.

• Always keep out of reach of children and pets.

• Do not use if past expiry or if the packaging is damaged.

• Levocetirizine + Montelukast (Levocetirizine + Montelukast) has a favourable food interaction profile. Food does not significantly affect absorption or efficacy, so the tablet can be taken with or without meals.

• Avoid alcohol as it enhances sedation, dizziness, and CNS depression risks.

• Grapefruit juice is not a significant contraindication, but inform your doctor if consumed in large amounts, as it may alter drug metabolism.

• Maintain a balanced diet and good hydration to support symptom control and soothe allergy-related throat discomfort.

• Avoid combining with other CNS depressants (e.g., sedatives, opioids) to prevent enhanced drowsiness and respiratory depression risk.

• Montelukast typically does not significantly interact with common drugs but may require monitoring with enzyme inducers.

• Levocetirizine has a low potential for liver enzyme interactions.

• Always inform your doctor about all medications and supplements.

• Use caution in patients with kidney impairment; dosage adjustment may be necessary since Levocetirizine is primarily cleared renally.

• Avoid in patients prone to urinary retention, such as those with prostate enlargement.

• Monitor seizure disorder patients carefully; rare seizures reported.

• Advise caution in severe liver impairment despite minimal hepatic metabolism.

Take the missed dose as soon as you remember unless it is near the time of your next dose. Do not double doses to make up. Maintaining a regular dosing schedule helps control symptoms effectively.